# iO Urology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/io-urology

- Industry: Medical Devices & Equipment
- Headquarters: Knoxville, US
- Website: www.i-ourology.com
- Total disclosed funding: $19M
- Latest round: Series A (Mar 29, 2024)
- Investors on record: 4

## About

Based in Tennessee, US, and founded in 2020, I-O Urology Corp., a.k.a. I-O Urology operates as a medical technology company developing remote patient monitoring solutions for managing lower urinary tract symptoms (LUTS). In March 2024, iO Urology raised USD 19.4 million in a Series A funding led by Solas BioVentures, with participation from Launch Tennessee, Jumpstart Capital, and Laborie Medical Technologies Corp.
 

The company provides the CarePath® platform, a complete digital diagnostic platform designed for remote, real-time measurement of urine output. CarePath is a portable product that provides real-time, quantitative measurement of uroflow and urine output, resulting in increased patient engagement, improving compliance, and standardizing treatment pathways for lower urinary tract symptoms (LUTS).

The company plans to use its proceeds from March 2024 funding to speed up its development and market advancement.

## Funding rounds

- Series A, Mar 29, 2024, $19M — Jumpstart Capital, Laborie Medical Technologies Corp., Solas BioVentures, Launch Tennessee

## Investors

- Jumpstart Capital — Series A
- Laborie Medical Technologies Corp. — Series A
- Solas BioVentures (https://capitalatlas.ai/funds/solas-bioventures) — Series A
- Launch Tennessee (https://capitalatlas.ai/funds/launch-tennessee) — Series A